Cepheid (CPHD)

Add to Watchlists
Create an Alert
46.14 +0.01  +0.02% NASDAQ Apr 15, 8:00PM BATS Real time Currency in USD
View Full Chart
CPHD Price Chart
View All Events

CPHD Events

Date Type Description
Apr 17 Misc Q1 2014 Cepheid Earnings Conference Call
Apr 17 Earnings Q1 2014 Cepheid Earnings Results. Estimate: -0.19.
Jan 30 Misc Cepheid 2013 Fourth Quarter Earnings Conference Call
Jan 30 Earnings Cepheid Q4 2013 Earnings Conference Call. Estimate: -0.10.
Oct 17 Misc Q3 2013 Cepheid Earnings Conference Call
Oct 17 Earnings Cepheid Schedules 2013 Third Quarter Results Announcement and Webcast. Estimate: -0.11.
Apr 30 Misc AGM Event for Cepheid
Apr 18 Misc Cepheid Schedules 2013 First Quarter Results Announcement and Webcast
Apr 18 Earnings Q1 Earnings Result. Estimate: -0.02.
View All Performance Charts

CPHD Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cepheid is up 21.97% over the last year vs S&P 500 Total Return up 18.46%, AngioDynamics up 31.29%, and Natus Medical up 74.25%.

Get Quote for

Pro Report PDF for CPHD

Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download CPHD Pro Report PDF

Pro Strategies Featuring CPHD

Did Cepheid make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.

CPHD Profile

  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: California
  • Current Fiscal Year End: December 31, 2014
  • NAICS: Analytical Laboratory Instrument Manufacturing
  • NAICS Code: 334516
  • NAICS Industry: Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • NAICS Industry Code: 3345
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 33

Cepheid is a broad-based molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for testing in the clinical market, as well as for application in the biothreat, industrial and partner markets. The company's two principal systems are the GeneXpert and SmartCycler. The GeneXpert system integrates sample preparation in addition to DNA amplification and detection. The SmartCycler system integrates DNA amplification and detection to allow rapid analysis of a sample. The GeneXpert Infinity System uses robotic cartridge handling and a full touch screen driven menu, to run up to 1,300 different molecular tests during any 24-hour period, depending upon test selection. The company was founded in 1996 and is based in Sunnyvale, California.

Recent Quotes

Symbol Price Chg Chg % Market Cap
CPHD 46.14 +0.01 +0.02% 3.202B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership


{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.